Erste Group downgraded UnitedHealth (UNH) to Hold from Buy. A recent civil investigation by the Department of Justice into the accuracy of patient billings covered by the Medicare Advantage Plan increases economic uncertainty for investors, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Senator Grassley probing UnitedHealth billing practices, WSJ reports
- UnitedHealth drops 1% to $454.01 after WSJ report of Grassley probe
- UnitedHealth price target lowered to $560 from $610 at Argus
- UnitedHealth’s Strategic Positioning and Valuation Justify Buy Rating Amid DOJ Scrutiny
- Morgan Stanley views move in UnitedHealth’s shares as ‘seemingly overdone’